NovaBridge Biosciences Lessee, Operating Lease, Liability, Undiscounted Excess Amount
NovaBridge Biosciences (NBP) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $358.00 thousand as of 2025-12-31, per its 20-F filed 2026-04-07.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-04-07
- 2023-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount 5.01M CNY.
- 2022-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount 24.98M CNY.
- 2021-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount 10.18M CNY.
- 2020-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.30M CNY.
CNY
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2023-12-31 | 5.01M CNY 20-F · filed 2024-04-30 |
| 2022-12-31 | 24.98M CNY 20-F · filed 2023-05-01 |
| 2021-12-31 | 10.18M CNY 20-F · filed 2022-04-29 |
| 2020-12-31 | 1.30M CNY 20-F · filed 2021-04-28 |
| 2019-12-31 | 1.14M CNY 20-F · filed 2020-04-29 |
USD
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2025-12-31 | $358.00K 20-F · filed 2026-04-07 |
| 2025-09-30 | $402.00K 6-K · filed 2025-12-18 |
| 2025-06-30 | $448.00K 6-K · filed 2025-10-06 |
| 2024-12-31 | $552.00K 20-F · filed 2025-04-03 |
| 2023-12-31 | $705.00K 20-F · filed 2024-04-30 |
| 2022-12-31 | $3.62M 20-F · filed 2023-05-01 |
| 2021-12-31 | $1.60M 20-F · filed 2022-04-29 |
| 2020-12-31 | $199.00K 20-F · filed 2021-04-28 |
| 2019-12-31 | $163.00K 20-F · filed 2020-04-29 |